New Delhi: India will now be able to detect the Nipah virus within minutes as the National Institute of Virology (NIV) in Pune, under the Indian Council of Medical Research (ICMR), has developed a portable ‘point-of-care’ test kit for detecting the virus.
This kit can provide instant results even outside laboratory settings and will be deployed soon in high-risk areas like Kerala and West Bengal, Dr Naveen Kumar, the director of NIV, said.
“We have developed a LAMP-based portable kit for quick and reliable detection of the Nipah virus. It provides results in just a few minutes without the need for a laboratory. The kit has also been patented,” Dr Kumar said.
The Nipah virus primarily spreads through fruit bats and has caused several outbreaks in India.
With a mortality rate exceeding 50 per cent, it is one of the most lethal viral diseases.
In India, the capability to culture the Nipah virus exists only at NIV Pune, where genomic analysis, vaccine development, and drug testing are also carried out, said Dr Pragya Yadav, senior scientist at NIV.
The NIV is working with a pharma company and research partners to develop monoclonal antibodies to treat Nipah. Additionally, the institute is also working on an indigenous vaccine for the Nipah virus, which is expected to enter trial phases in the coming years.
According to data, the Nipah virus samples found in India so far belong to the ‘Genotype B’ category, seen in both Bangladesh and India, Dr Kumar said.
This variant spreads rapidly and causes severe symptoms, whereas the Malaysian variant (Genotype M) is comparatively less infectious.
Over the past decade, most Nipah virus cases in India have been reported from Kerala and West Bengal, he said. The NIV has set up specialised labs and monitoring systems in these states to enable early detection and containment, Dr Kumar added.